TBPH

NASDAQStock

Theravance Biopharma, Inc.

$13.64-0.24 (-1.76%)

52-Week Range

$8.32

$20.74

Key Stats

Market Cap

691.4M

P/E Ratio

—

Dividend Yield

—

Beta

0.11

Volume

378.4K

Avg Volume

1.1M

Performance

-28.40%

-21.83%

-3.54%

YTD

-23.47%

+50.49%

+31.53%

-32.57%

Price Chart

ETF Exposure

TBPH is held by 102 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	45,461	$49K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	45,461	$15K	$3.91B	0.07%

PreviousPage 3 of 3

About TBPH ETF Exposure

Theravance Biopharma, Inc. (TBPH) is held by 102 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 691.4M, TBPH is a widely held institutional stock. The stock currently trades at $13.64. Investors can gain exposure to TBPH through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TBPH, sorted by portfolio weight.